Sunday, April 25, 2021

Biocon Biologics, Viatris receive EC nod for biosimilar Bevacizumab

Biocon Biologics, Viatris receive EC nod for biosimilar Bevacizumab The nod came following the positive recommendation by the Committee for Medicinal Products for Human Use of the European Medicines Agency, it said.

from Moneycontrol Business News https://ift.tt/3nneASz

No comments:

Post a Comment

US equities end lower as valuation concerns creep in

U.S. stocks closed lower on Wednesday as investors took profits amid concerns about high valuations flagged by Fed Chair Powell. The market ...